Papanikolaou, X
Alapat, D
Rosenthal, A
Stein, C
Epstein, J
Owens, R
Yaccoby, S
Johnson, S
Bailey, C
Heuck, C
Tian, E
Joiner, A
van Rhee, F
Khan, R
Zangari, M
Jethava, Y
Waheed, S
Davies, F
Morgan, G
Barlogie, B
Article History
Received: 24 November 2014
Revised: 12 February 2015
Accepted: 23 February 2015
First Online: 10 March 2015
Competing interests
: BB received research funding from Celgene Corp. and Millennium Pharmaceuticals, Inc. and is a consultant for Celgene Corp., Millennium Pharmaceuticals, Inc., Onyx Pharmaceuticals, Inc., and Amgen, Inc. He is a co-inventor on patents and patent applications related to use of gene expression profiling in cancer medicine that have been licensed to Myeloma Health, LLC, but has no financial interests in this company. The remaining authors declare no conflict of interest.